aspirin and semaglutide Weight loss drug could reduce heart attack risk by 20%, study finds | Medical research 🎙️ Rounds Table — Infographics

This is exactly why having multiple dual-agonist options available is valuable for the field

Introduction : Cardiovascular disease (CVD) remains a leading cause of mortality worldwide, emphasizing the need for effective prevention and management strategies

A 2025 cohort study in JAMA Network Open found no significant association between preoperative GLP-1 receptor agonist use and short-term postoperative aspiration pneumonia among adults undergoing surgery

Safety and Side Effects: What to Expect Like all medicines, Oral Wegovy has side effects

People who accepted Semaglutide dropped 12.4 % of their primary body weight compared to individuals who received a placebo